Issued Patents 2023
Showing 1–11 of 11 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 11834436 | Tetrazole containing apoptosis signal-regulating kinase 1 inhibitors and methods of use thereof | Guoqiang Wang, Ruichao Shen, Brett Granger, Jing He, Xuechao Xing +4 more | 2023-12-05 |
| 11802125 | Functionalized heterocyclic compounds as antiviral agents | Joseph Panarese, Dexter Davis, Nathaniel Thomas Kenton, Samuel Bartlett | 2023-10-31 |
| 11760755 | Hepatitis B antiviral agents | Yao-Ling Qiu, Xiaowen Peng, Xuri Gao, Wei Li, Hui Cao +3 more | 2023-09-19 |
| 11753403 | EIF4E inhibitors and uses thereof | Christopher L. VANDEUSEN, Alan E. Walts | 2023-09-12 |
| 11738019 | Substituted heterocycles as antiviral agents | Joseph Panarese, Samuel Bartlett, Dexter Davis, Nathaniel Thomas Kenton | 2023-08-29 |
| 11718641 | Bile acid derivatives as FXR/TGR5 agonists and methods of use thereof | Guoqiang Wang, Ruichao Shen, Jiang Long, Peng Dai, Xuechao Xing +1 more | 2023-08-08 |
| 11596611 | Hepatitis B antiviral agents | Yao-Ling Qiu, Xuri Gao, Jorden Kass, Hui Cao, Wei Li +2 more | 2023-03-07 |
| 11578097 | Tetrazole derivatives of bile acids as FXR/TGR5 agonists and methods of use thereof | Jing He, Guoqiang Wang | 2023-02-14 |
| 11572367 | Antiviral heterocyclic compounds | Adam Szymaniak, Kevin McGrath, Jianming Yu, Tyler Mann, Long Nguyen +2 more | 2023-02-07 |
| 11560368 | Apoptosis signal-regulating kinase 1 inhibitors and methods of use thereof | Guoqiang Wang, Ruichao Shen, Jiang Long, Jun Ma, Xuechao Xing +4 more | 2023-01-24 |
| 11555032 | Isoxazole derivatives as FXR agonists and methods of use thereof | Guoqiang Wang, Jun Ma, Bin Wang, Ruichao Shen, Xuechao Xing +1 more | 2023-01-17 |